Research for Most Active Stocks: Johnson & Johnson, Scotts Miracle-Gro, Merck, Best Buy, Devon Energy, and Chevron

VANCOUVER, British Columbia, June 14, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Johnson & Johnson (NYSE:JNJ), Scotts Miracle-Gro (NYSE:SMG), Merck (NYSE:MRK), Best Buy (NYSE:BBY), Devon Energy (NYSE:DVN), and Chevron (NYSE:CVX).

(Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO )

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

Johnson & Johnson (NYSE:JNJ): Share price of Johnson & Johnson jumped up 2.17% to US$64.45 with 98.44 million shares trading hands, compare to its average volume of 12.78 million shares. Johnson & Johnson spent US$19.7 billion on purchasing Synthes Inc. (SYST). The deal is the biggest acquisition during the company's history. Academic studies clarify that professional investors can get benefit from insider trading data. Do you want to trace this company on an on-going basis? It can be done for free by registering below.

Read Full Report: http://www.insiderslab.com/PR3/061412A/JNJ/JohnsonJohnson.pdf

Scotts Miracle-Gro Co. (NYSE:SMG): According Forbes, Scotts Miracle-Gro Co. (NYSE:SMG) recently announced it expects to come in short of its full-year profit estimates. CEO Jim Hagedorn admitted that the initial forecast of 6% to 8% sales growth and earnings of US$2.65 to US$2.85 per share were a bit too lofty, and the gross margins would also be affected. The media outlet stated that fault could be placed on Hagedorn and the rest of the company's management, who emptied US$40 million into new advertising at a time when the company was already dominating the market. But despite this advertising blitz, sales remained flat. "The strategy clearly did not work this year," said CL King analyst Jim Barrett, "and we think there is no reason to believe it will work next year either."  Information on insider trading shows that in that in the last three months, company insiders have sold US$2.09 million in shares, valued between US$47.30 and US$54.50 each. Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to trace the activities of company insiders from now on?

Read Full Report: http://www.insiderslab.com/PR3/061412A/SMG/ScottsMiracle-Gro.pdf

Merck & Co., Inc. (NYSE:MRK): Shares of Merck & Co., Inc. (NYSE:MRK) slid slightly on Wednesday despite an announcement that the company's new sleep aid could soon rival Ambien.  According to The Wall Street Journal, insomnia patients taking an experimental sleep aid developed by Merck nodded off faster and stayed asleep longer than those taking placebos. The drug, suvorexant, works by blocking the brain's reception of the chemical orexin, which creates alertness in the body. If the drug continues to succeed in clinical trials, it could open up a new market for sleep aids, as it can keep patients asleep longer than other drugs on the market, including Ambien. However, despite the promising results, the stock was down 0.18% as of 3:57 p.m. What's more, Richard Bowles III, executive vice president and chief ethics and compliance officer, exercised his market option on May 12 for 27,377 shares valued at US$20.66, then sold those shares for US$38.50 each for a profit of US$484,390, according to insider trades filed with the SEC. Why do you think Bowles is selling his shares? Do you think now is a good time to buy or sell its stock? Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in MRK are starting to buy more company shares. See insider trade report for MRK here.

Read Full Report: http://www.insiderslab.com/PR3/061412A/MRK/Merck.pdf

Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.

Best Buy Co., Inc. (NYSE:BBY):
Read Full Report: http://www.insiderslab.com/PR3/061412A/BBY/BestBuy.pdf

Devon Energy Corporation (NYSE:DVN):
Read Full Report: http://www.insiderslab.com/PR3/061412A/DVN/DevonEnergy.pdf

Chevron Corporation (NYSE:CVX):
Read Full Report: http://www.insiderslab.com/PR3/061412A/CVX/Chevron.pdf

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Insiderslab.com:

Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer: 
Please visit insiderslab.com/disclaimers/disclaimers.php for details.

SOURCE Insiderslab.com; Insiders.hk